Nektar Therapeutics - Common Stock (NKTR)

CUSIP: 640268108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
20,788,527
Total 13F shares
169,693,928
Share change
-2,784,589
Total reported value
$3,392,531,228
Put/Call ratio
96%
Price per share
$20.00
Number of holders
224
Value change
-$52,781,602
Number of buys
90
Number of sells
113

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NKTR - Nektar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Invesco Ltd.
13F
Company
171%
35,456,949
$602,768,000 31 Dec 2020
13F
FMR LLC
13F
Company
91%
18,949,685
$322,145,000 31 Dec 2020
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
89%
18,440,399
$313,487,000 31 Dec 2020
13F
BlackRock Finance, Inc.
13F
Company
88%
18,378,080
$312,426,000 31 Dec 2020
13F
VANGUARD GROUP INC
13F
Company
78%
16,272,585
$276,634,000 31 Dec 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
64%
13,392,612
$227,674,000 31 Dec 2020
13F
MAVERICK CAPITAL LTD
13F
Company
32%
6,655,625
$113,146,000 31 Dec 2020
13F
STATE STREET CORP
13F
Company
22%
4,475,576
$76,085,000 31 Dec 2020
13F
Bellevue Group AG
13F
Company
19%
3,866,258
$65,726,000 31 Dec 2020
13F
FIRST TRUST ADVISORS LP
13F
Company
18%
3,814,215
$64,842,000 31 Dec 2020
13F
Camber Capital Management LP
13F
Company
12%
2,500,000
$42,500,000 31 Dec 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
11%
2,285,776
$38,858,000 31 Dec 2020
13F
NORGES BANK
13F
Company
11%
2,191,199
$37,250,000 31 Dec 2020
13F
Bank of New York Mellon Corp
13F
Company
8.3%
1,733,073
$29,463,000 31 Dec 2020
13F
NORTHERN TRUST CORP
13F
Company
6.7%
1,386,373
$23,569,000 31 Dec 2020
13F
Rhenman & Partners Asset Management AB
13F
Company
6.5%
1,350,000
$22,950,000 31 Dec 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
5%
1,029,234
$17,497,000 31 Dec 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
4.8%
1,001,361
$17,024,000 31 Dec 2020
13F
D. E. Shaw & Co., Inc.
13F
Company
4.7%
987,014
$16,780,000 31 Dec 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
3.8%
783,969
$13,336,000 31 Dec 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3%
620,838
$10,554,000 31 Dec 2020
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
2.7%
568,379
$9,662,000 31 Dec 2020
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
2.7%
568,053
$9,657,000 31 Dec 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.6%
548,893
$9,331,000 31 Dec 2020
13F
Nuveen Asset Management, LLC
13F
Company
2.6%
537,242
$9,133,000 31 Dec 2020
13F
RHUMBLINE ADVISERS
13F
Company
2.4%
497,517
$8,458,000 31 Dec 2020
13F
MORGAN STANLEY
13F
Company
2.2%
463,685
$7,884,000 31 Dec 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
2.2%
450,529
$7,659,000 31 Dec 2020
13F
OSTERWEIS CAPITAL MANAGEMENT INC
13F
Company
2%
424,504
$7,217,000 31 Dec 2020
13F
Swiss National Bank
13F
Company
1.9%
404,500
$6,877,000 31 Dec 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
1.6%
323,632
$5,502,000 31 Dec 2020
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.5%
308,660
$5,247,000 31 Dec 2020
13F
S.c.a. Candriam
13F
Individual
1.5%
306,085
$5,204,000 31 Dec 2020
13F
Legal & General Group Plc
13F
Company
1.5%
302,185
$5,137,000 31 Dec 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
1.5%
302,095
$5,136,000 31 Dec 2020
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
1.3%
280,161
$4,763,000 31 Dec 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.3%
276,874
$4,707,000 31 Dec 2020
13F
US BANCORP \DE\
13F
Company
1.3%
275,024
$4,676,000 31 Dec 2020
13F
IEQ CAPITAL, LLC
13F
Company
1.3%
266,559
$4,532,000 31 Dec 2020
13F
MACQUARIE GROUP LTD
13F
Company
1.3%
265,802
$4,519,000 31 Dec 2020
13F
BLAIR WILLIAM & CO/IL
13F
Company
1.3%
265,680
$4,517,000 31 Dec 2020
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
1.2%
255,628
$4,346,000 31 Dec 2020
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
1.2%
254,093
$4,319,581 31 Dec 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
1.2%
253,515
$4,310,000 31 Dec 2020
13F
CREDIT SUISSE AG/
13F
Company
1.2%
240,989
$4,096,000 31 Dec 2020
13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM
13F
Company
1.1%
237,288
$4,034,000 31 Dec 2020
13F
Retirement Systems of Alabama
13F
Company
1.1%
233,840
$3,975,000 31 Dec 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
1.1%
229,300
$3,898,000 31 Dec 2020
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
1%
216,226
$3,676,000 31 Dec 2020
13F
York State Teachers Retirement System New
13F
Individual
1%
214,100
$3,640,000 31 Dec 2020
13F

Institutional Holders of Nektar Therapeutics - Common Stock (NKTR) as of Q1 2021

As of 31 Mar 2021, Nektar Therapeutics - Common Stock (NKTR) was held by 224 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 169,693,928 shares. The largest 10 holders included Invesco Ltd., BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, MAVERICK CAPITAL LTD, STATE STREET CORP, FIRST TRUST ADVISORS LP, and Bellevue Group AG. This page lists 225 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
232
Q1 2021 holders
224
Holder diff
-8
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.